PMID: 2495039Mar 1, 1989Paper

Some characteristics of aggregates of IgG and plasma proteins in heat-treated factor VIII concentrates

Blut
C WadsworthM Blombäck

Abstract

Eight batches of commercial heat-treated and one untreated factor VIII concentrate from 6 producers were analyzed for their content of IgG, IgG subclasses, IgG aggregates and the presence of other plasma proteins combined with the IgG as well as for anticomplement activity. Methods used were thin-layer gel filtration, immuno-gel filtration, spot immuno-precipitate assay in a double antibody version and an agarose plate haemolysis inhibition assay of complement fixation. The IgG content varied from 0.1-6.90 g/l. In all preparations IgG existed as monomers and aggregates. Associated with the IgG were also found, at significantly increased amounts compared to normal serum and intravenous immunoglobulin, one to four of the following plasma proteins; fibronectin, fibrinogen, von Willebrand factor antigen, Clq, albumin and IgA. Three batches from two producers had high anticomplementary activity, presumably caused by the IgG aggregates. Two of these deviated strikingly from normal human serum pools in percent distribution of IgG subclasses. It is hypothesized that these aggregates can induce side effects or cause immunological aberrations.

References

Aug 1, 1977·Annals of Internal Medicine·M E EysterJ N Haverstick
Jan 1, 1976·Scandinavian Journal of Immunology·S AhlstedtC Wadsworth
Nov 1, 1988·European Journal of Haematology·B BöttigerG Biberfeld
Jan 1, 1987·International Archives of Allergy and Applied Immunology·J W MannhalterM M Eibl
Jan 1, 1988·American Journal of Hematology·D L Aronson
Jan 1, 1974·Scandinavian Journal of Immunology·C Wadsworth
Jan 1, 1971·International Archives of Allergy and Applied Immunology·L A HansonC Wadsworth
Jan 15, 1983·Lancet·P JonesS George
Dec 1, 1980·The American Journal of Medicine·R E HelmerJ A Grant
Mar 1, 1981·The Journal of Clinical Investigation·A DurandyC Griscelli
Aug 15, 1984·Thrombosis Research·L Thorell, B Blombäck
Jan 1, 1962·Vox Sanguinis·S BARANDUNH ISLIKER

❮ Previous
Next ❯

Citations

Jun 1, 1992·Biologicals : Journal of the International Association of Biological Standardization·T Burnouf
Mar 1, 2008·Intervirology·Hidenori ToyodaJunki Takamatsu
Nov 1, 1992·Scandinavian Journal of Clinical and Laboratory Investigation·K H EllegårdJ Ingerslev

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibodies: Complement Activation

The complement system can be activated by antigen-associated antibody. In the classical pathway of complement activation, C1q, C4b, and C3b are all able to bind to the Fc portion of IgG or IgM. Find the latest research on antibodies and complement activation here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.